PARDES BIOSCIENCES, INC. Quarterly Debt-to-equity in % from Q3 2021 to Q2 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Pardes Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q2 2023.
  • Pardes Biosciences, Inc. Debt-to-equity for the quarter ending June 30, 2023 was 6.52 %, a 18.3% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2023 6.52 +1.01 +18.3% Jun 30, 2023
Q1 2023 7.16 -0.83 -10.4% Mar 31, 2023
Q4 2022 6.16 -12.3 -66.7% Dec 31, 2022
Q3 2022 4.37 +50 Sep 30, 2022
Q2 2022 5.51 Jun 30, 2022
Q1 2022 7.99 Mar 31, 2022
Q4 2021 18.5 Dec 31, 2021
Q3 2021 -45.7 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.